O	O	0	7	Alcohol	Alcohol	B-NP	NN	O	4	NMOD	O
O	O	7	8	-	-	B-NP	HYPH	O	1	P	O
O	O	8	15	induced	induce	I-NP	VBN	O	4	NMOD	O
O	O	16	26	regulation	regulation	I-NP	NN	O	0	ROOT	O
O	O	27	29	of	of	B-PP	IN	O	4	NMOD	O
T12	B-Entity	30	37	nuclear	nuclear	B-NP	JJ	B-protein	8	NMOD	B-protein
T12	I-Entity	38	48	regulatory	regulatory	I-NP	JJ	I-protein	8	NMOD	I-protein
T12	I-Entity	49	55	factor	factor	I-NP	NN	I-protein	11	NMOD	I-protein
T12	I-Entity	55	56	-	-	O	HYPH	I-protein	11	NMOD	I-protein
T12	I-Entity	56	61	kappa	kappa	B-NP	NN	I-protein	11	NMOD	I-protein
T12	I-Entity	62	66	beta	beta	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	67	69	in	in	B-PP	IN	O	4	NMOD	O
O	O	70	75	human	human	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	76	85	monocytes	monocyte	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	85	86	.	.	O	.	O	4	P	O

O	O	88	93	Acute	Acute	B-NP	JJ	O	3	NMOD	O
O	O	94	101	ethanol	ethanol	I-NP	NN	O	3	NMOD	O
O	O	102	110	exposure	exposure	I-NP	NN	O	4	SUB	O
O	O	111	114	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	115	118	the	the	B-NP	DT	O	6	NMOD	O
O	O	119	127	capacity	capacity	I-NP	NN	O	4	OBJ	O
O	O	128	130	to	to	B-VP	TO	O	8	VMOD	O
O	O	131	139	modulate	modulate	I-VP	VB	O	6	NMOD	O
O	O	140	146	immune	immune	B-NP	JJ	O	10	NMOD	O
O	O	147	156	functions	function	I-NP	NNS	O	8	OBJ	O
O	O	156	157	,	,	O	,	O	8	P	O
O	O	158	170	particularly	particularly	B-ADVP	RB	O	16	VMOD	O
O	O	170	171	,	,	O	,	O	16	P	O
O	O	172	174	to	to	B-VP	TO	O	16	VMOD	O
O	O	175	179	down	down	I-VP	RB	O	16	VMOD	O
O	O	180	188	regulate	regulate	I-VP	VB	O	8	VMOD	O
O	O	189	197	monocyte	monocyte	B-NP	NN	O	18	NMOD	O
O	O	198	208	production	production	I-NP	NN	O	16	OBJ	O
O	O	209	211	of	of	B-PP	IN	O	18	NMOD	O
O	O	212	224	inflammatory	inflammatory	B-NP	JJ	B-protein	21	NMOD	B-protein
O	O	225	234	cytokines	cytokine	I-NP	NNS	I-protein	19	PMOD	I-protein
O	O	234	235	.	.	O	.	O	4	P	O

O	O	236	243	However	However	B-ADVP	RB	O	11	VMOD	O
O	O	243	244	,	,	O	,	O	11	P	O
O	O	245	248	the	the	B-NP	DT	O	5	NMOD	O
O	O	249	262	intracellular	intracellular	I-NP	JJ	O	5	NMOD	O
O	O	263	273	mechanisms	mechanism	I-NP	NNS	O	11	SUB	O
O	O	274	277	for	for	B-PP	IN	O	5	NMOD	O
O	O	278	283	these	these	B-NP	DT	O	8	NMOD	O
O	O	284	291	effects	effect	I-NP	NNS	O	6	PMOD	O
O	O	292	294	of	of	B-PP	IN	O	8	NMOD	O
O	O	295	302	ethanol	ethanol	B-NP	NN	O	9	PMOD	O
O	O	303	306	are	be	B-VP	VBP	O	0	ROOT	O
O	O	307	310	yet	yet	I-VP	RB	O	11	VMOD	O
O	O	311	313	to	to	I-VP	TO	O	14	VMOD	O
O	O	314	316	be	be	I-VP	VB	O	11	VMOD	O
O	O	317	327	understood	understand	I-VP	VBN	O	14	VC	O
O	O	327	328	.	.	O	.	O	11	P	O

O	O	329	340	Considering	Consider	B-VP	VBG	O	35	VMOD	O
O	O	341	345	that	that	B-SBAR	IN	O	1	VMOD	O
T13	B-Entity	346	353	nuclear	nuclear	B-NP	JJ	B-protein	5	NMOD	B-protein
T13	I-Entity	354	364	regulatory	regulatory	I-NP	JJ	I-protein	5	NMOD	I-protein
T13	I-Entity	365	371	factor	factor	I-NP	NN	I-protein	8	NMOD	I-protein
T13	I-Entity	371	372	-	-	O	HYPH	O	8	NMOD	O
T13	I-Entity	372	377	kappa	kappa	B-NP	NN	O	8	NMOD	O
T13	I-Entity	378	382	beta	beta	I-NP	NN	O	16	NMOD	O
T13	I-Entity	383	384	(	(	O	(	O	14	DEP	O
T13	I-Entity	384	386	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T13	I-Entity	386	387	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T13	I-Entity	387	392	kappa	kappa	I-NP	NN	I-protein	13	NMOD	I-protein
T13	I-Entity	393	394	B	B	I-NP	NN	I-protein	14	DEP	I-protein
T13	I-Entity	394	395	)	)	O	)	O	8	NMOD	O
T13	I-Entity	395	396	/	/	B-NP	SYM	O	16	NMOD	O
T13	I-Entity	396	399	Rel	Rel	I-NP	NN	B-protein	17	SUB	B-protein
O	O	400	402	is	be	B-VP	VBZ	O	2	SBAR	O
O	O	403	404	a	a	B-NP	DT	O	19	NMOD	O
O	O	405	411	common	common	I-NP	JJ	O	17	PRD	O
O	O	412	422	regulatory	regulatory	I-NP	JJ	B-DNA	21	NMOD	B-DNA
O	O	423	430	element	element	I-NP	NN	I-DNA	19	NMOD	I-DNA
O	O	431	433	of	of	B-PP	IN	O	19	NMOD	O
O	O	434	437	the	the	B-NP	DT	O	25	NMOD	O
T14	B-Entity	438	446	promoter	promoter	I-NP	NN	B-DNA	25	NMOD	B-DNA
T14	I-Entity	447	453	region	region	I-NP	NN	I-DNA	22	PMOD	I-DNA
T14	I-Entity	454	456	of	of	B-PP	IN	O	25	NMOD	O
T14	I-Entity	457	460	the	the	B-NP	DT	O	30	NMOD	O
T14	I-Entity	461	473	inflammatory	inflammatory	I-NP	JJ	B-DNA	30	NMOD	B-DNA
T14	I-Entity	474	482	cytokine	cytokine	I-NP	NN	I-DNA	30	NMOD	I-DNA
T14	I-Entity	483	488	genes	gene	I-NP	NNS	I-DNA	26	PMOD	I-DNA
O	O	488	489	,	,	O	,	O	32	P	O
O	O	490	496	herein	herein	B-ADVP	RB	O	19	NMOD	O
O	O	496	497	,	,	O	,	O	35	P	O
O	O	498	500	we	we	B-NP	PRP	O	35	SUB	O
O	O	501	507	tested	test	B-VP	VBD	O	0	ROOT	O
O	O	508	511	the	the	B-NP	DT	O	37	NMOD	O
O	O	512	522	hypothesis	hypothesis	I-NP	NN	O	35	OBJ	O
O	O	523	527	that	that	B-SBAR	IN	O	37	NMOD	O
O	O	528	533	acute	acute	B-NP	JJ	O	40	NMOD	O
O	O	534	541	ethanol	ethanol	I-NP	NN	O	41	SUB	O
O	O	542	549	affects	affect	B-VP	VBZ	O	38	SBAR	O
T17	B-Entity	550	552	NF	NF	B-NP	NN	B-protein	46	NMOD	B-protein
T17	I-Entity	552	553	-	-	I-NP	HYPH	I-protein	46	NMOD	I-protein
T17	I-Entity	553	558	kappa	kappa	I-NP	NN	I-protein	46	NMOD	I-protein
T17	I-Entity	559	560	B	B	I-NP	NN	I-protein	46	NMOD	I-protein
O	O	561	571	activation	activation	I-NP	NN	O	41	OBJ	O
O	O	572	574	in	in	B-PP	IN	O	46	NMOD	O
O	O	575	580	human	human	B-NP	JJ	B-cell_type	49	NMOD	B-cell_type
O	O	581	590	monocytes	monocyte	I-NP	NNS	I-cell_type	47	PMOD	I-cell_type
O	O	590	591	.	.	O	.	O	35	P	O

O	O	592	601	Adherence	Adherence	B-NP	NN	O	4	NMOD	O
O	O	601	602	-	-	B-NP	HYPH	O	1	P	O
O	O	602	610	isolated	isolate	I-NP	VBN	O	4	NMOD	O
O	O	611	620	monocytes	monocyte	I-NP	NNS	B-cell_type	5	SUB	B-cell_type
O	O	621	627	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	628	640	constitutive	constitutive	B-NP	JJ	O	9	NMOD	O
T18	B-Entity	641	644	DNA	DNA	I-NP	NN	O	9	NMOD	O
O	O	645	652	binding	binding	I-NP	NN	O	9	NMOD	O
O	O	653	661	activity	activity	I-NP	NN	O	5	OBJ	O
O	O	662	664	of	of	B-PP	IN	O	9	NMOD	O
T19	B-Entity	665	667	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T19	I-Entity	667	668	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T19	I-Entity	668	673	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T19	I-Entity	674	675	B	B	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	675	676	.	.	O	.	O	5	P	O

O	O	677	678	A	A	B-NP	DT	O	4	NMOD	O
O	O	679	689	clinically	clinically	I-NP	RB	O	3	AMOD	O
O	O	690	698	relevant	relevant	I-NP	JJ	O	4	NMOD	O
O	O	699	703	dose	dose	I-NP	NN	O	15	SUB	O
O	O	704	705	(	(	O	(	O	8	DEP	O
O	O	705	707	25	25	B-NP	CD	O	7	NMOD	O
O	O	708	710	mM	mM	I-NP	NN	O	8	DEP	O
O	O	710	711	)	)	O	)	O	4	NMOD	O
O	O	712	714	of	of	B-PP	IN	O	4	NMOD	O
O	O	715	720	acute	acute	B-NP	JJ	O	12	NMOD	O
O	O	721	728	ethanol	ethanol	I-NP	NN	O	12	NMOD	O
O	O	729	738	treatment	treatment	I-NP	NN	O	9	PMOD	O
O	O	739	741	in	in	B-ADVP	FW	O	4	NMOD	O
O	O	742	747	vitro	vitro	I-ADVP	FW	O	13	AMOD	O
O	O	748	757	increased	increase	B-NP	VBN	O	21	NMOD	O
T20	B-Entity	758	760	NF	NF	I-NP	NN	B-protein	21	NMOD	B-protein
T20	I-Entity	760	761	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T20	I-Entity	761	766	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T20	I-Entity	767	768	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	769	776	binding	binding	I-NP	NN	O	21	NMOD	O
O	O	777	785	activity	activity	I-NP	NN	O	45	SUB	O
O	O	786	788	in	in	B-PP	IN	O	21	NMOD	O
O	O	789	798	monocytes	monocyte	B-NP	NNS	B-cell_type	22	PMOD	B-cell_type
O	O	799	803	with	with	B-PP	IN	O	21	NMOD	O
O	O	804	805	a	a	B-NP	DT	O	27	NMOD	O
O	O	806	818	preferential	preferential	I-NP	JJ	O	27	NMOD	O
O	O	819	828	induction	induction	I-NP	NN	O	24	PMOD	O
O	O	829	831	of	of	B-PP	IN	O	27	NMOD	O
O	O	832	835	the	the	B-NP	DT	O	39	NMOD	O
O	O	836	846	inhibitory	inhibitory	I-NP	JJ	O	39	NMOD	O
O	O	846	847	,	,	I-NP	,	O	39	P	O
T1	B-Protein	848	851	p50	p50	I-NP	NN	B-protein	39	NMOD	B-protein
O	O	851	852	/	/	I-NP	SYM	O	39	P	O
T2	B-Protein	852	855	p50	p50	B-NP	NN	B-protein	39	NMOD	B-protein
T21	B-Entity	855	856	,	,	O	,	O	39	P	O
T21	I-Entity	857	859	NF	NF	B-NP	NN	B-protein	39	NMOD	B-protein
T21	I-Entity	859	860	-	-	B-NP	HYPH	I-protein	39	NMOD	I-protein
T21	I-Entity	860	865	kappa	kappa	I-NP	NN	I-protein	39	NMOD	I-protein
T21	I-Entity	866	867	B	B	I-NP	NN	I-protein	42	NMOD	I-protein
T21	I-Entity	867	868	/	/	B-NP	SYM	O	42	NMOD	O
T21	I-Entity	868	871	Rel	Rel	I-NP	NN	B-protein	42	NMOD	B-protein
T21	I-Entity	872	881	homodimer	homodimer	I-NP	NN	I-protein	28	PMOD	I-protein
O	O	881	882	,	,	O	,	O	21	P	O
O	O	883	886	and	and	O	CC	O	21	VMOD	O
O	O	887	895	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	896	898	in	in	B-PP	IN	O	45	VMOD	O
O	O	899	901	no	no	B-NP	DT	O	48	NMOD	O
O	O	902	911	induction	induction	I-NP	NN	O	46	PMOD	O
O	O	912	914	of	of	B-PP	IN	O	48	NMOD	O
O	O	915	918	the	the	B-NP	DT	O	54	NMOD	O
T3	B-Protein	919	922	p65	p65	I-NP	NN	B-protein	54	NMOD	B-protein
O	O	922	923	/	/	B-NP	SYM	O	54	NMOD	O
T4	B-Protein	923	926	p50	p50	I-NP	NN	B-protein	54	NMOD	B-protein
T22	B-Entity	927	938	heterodimer	heterodimer	I-NP	NN	I-protein	49	PMOD	I-protein
O	O	938	939	.	.	O	.	O	45	P	O

O	O	940	942	In	In	B-PP	IN	O	7	VMOD	O
O	O	943	951	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	951	952	,	,	O	,	O	7	P	O
O	O	953	971	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	5	NMOD	O
O	O	972	983	stimulation	stimulation	I-NP	NN	O	7	SUB	O
O	O	984	993	primarily	primarily	B-ADVP	RB	O	7	VMOD	O
O	O	994	1001	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	1002	1005	the	the	B-NP	DT	O	12	NMOD	O
T5	B-Protein	1006	1009	p65	p65	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	1009	1010	/	/	B-NP	SYM	O	12	NMOD	O
T6	B-Protein	1010	1013	p50	p50	I-NP	NN	B-protein	12	NMOD	B-protein
T23	B-Entity	1014	1025	heterodimer	heterodimer	I-NP	NN	I-protein	7	OBJ	I-protein
O	O	1026	1030	that	that	B-NP	WDT	O	12	NMOD	O
O	O	1031	1034	has	have	B-VP	VBZ	O	13	SBAR	O
O	O	1035	1039	been	be	I-VP	VBN	O	14	VC	O
O	O	1040	1045	shown	show	I-VP	VBN	O	15	VC	O
O	O	1046	1048	to	to	I-VP	TO	O	18	VMOD	O
O	O	1049	1055	result	result	I-VP	VB	O	16	VMOD	O
O	O	1056	1058	in	in	B-PP	IN	O	18	VMOD	O
O	O	1059	1063	gene	gene	B-NP	NN	O	21	NMOD	O
O	O	1064	1074	activation	activation	I-NP	NN	O	19	PMOD	O
O	O	1074	1075	.	.	O	.	O	7	P	O

O	O	1076	1080	Thus	Thus	B-ADVP	RB	O	17	VMOD	O
O	O	1080	1081	,	,	O	,	O	17	P	O
O	O	1082	1086	such	such	B-NP	JJ	O	4	AMOD	O
O	O	1087	1093	unique	unique	I-NP	JJ	O	5	NMOD	O
O	O	1094	1104	activation	activation	I-NP	NN	O	17	SUB	O
O	O	1105	1107	of	of	B-PP	IN	O	5	NMOD	O
O	O	1108	1111	the	the	B-NP	DT	O	12	NMOD	O
O	O	1112	1122	inhibitory	inhibitory	I-NP	JJ	O	12	NMOD	O
T7	B-Protein	1123	1126	p50	p50	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	1126	1127	/	/	B-NP	SYM	O	12	NMOD	O
T8	B-Protein	1127	1130	p50	p50	I-NP	NN	B-protein	12	NMOD	B-protein
T24	B-Entity	1131	1140	homodimer	homodimer	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	1141	1143	by	by	B-PP	IN	O	5	NMOD	O
O	O	1144	1149	acute	acute	B-NP	JJ	O	16	NMOD	O
O	O	1150	1157	ethanol	ethanol	I-NP	NN	O	16	NMOD	O
O	O	1158	1167	treatment	treatment	I-NP	NN	O	13	PMOD	O
O	O	1168	1171	may	may	B-VP	MD	O	0	ROOT	O
O	O	1172	1178	result	result	I-VP	VB	O	17	VC	O
O	O	1179	1181	in	in	B-PP	IN	O	18	VMOD	O
O	O	1182	1192	inhibition	inhibition	B-NP	NN	O	23	NMOD	O
O	O	1193	1199	rather	rather	B-CONJP	RB	O	23	NMOD	O
O	O	1200	1204	than	than	I-CONJP	IN	O	21	DEP	O
O	O	1205	1215	activation	activation	B-NP	NN	O	33	NMOD	O
O	O	1216	1218	of	of	B-PP	IN	O	23	NMOD	O
T25	B-Entity	1219	1221	NF	NF	B-NP	NN	B-protein	28	NMOD	B-protein
T25	I-Entity	1221	1222	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T25	I-Entity	1222	1227	kappa	kappa	I-NP	NN	I-protein	28	NMOD	I-protein
T25	I-Entity	1228	1229	B	B	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	1229	1230	-	-	O	HYPH	O	23	P	O
O	O	1230	1239	regulated	regulate	B-VP	VBN	O	33	NMOD	O
T26	B-Entity	1240	1252	inflammatory	inflammatory	B-NP	JJ	B-DNA	33	NMOD	B-DNA
T26	I-Entity	1253	1261	cytokine	cytokine	I-NP	NN	I-DNA	33	NMOD	I-DNA
T26	I-Entity	1262	1267	genes	gene	I-NP	NNS	I-DNA	19	PMOD	I-DNA
O	O	1267	1268	.	.	O	.	O	17	P	O

O	O	1269	1281	Consequently	Consequently	B-ADVP	RB	O	5	VMOD	O
O	O	1281	1282	,	,	O	,	O	5	P	O
O	O	1283	1288	these	these	B-NP	DT	O	4	NMOD	O
O	O	1289	1296	results	result	I-NP	NNS	O	5	SUB	O
O	O	1297	1304	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1305	1309	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	1310	1325	physiologically	physiologically	B-NP	RB	O	8	AMOD	O
O	O	1326	1334	relevant	relevant	I-NP	JJ	O	9	NMOD	O
O	O	1335	1349	concentrations	concentration	I-NP	NNS	O	12	SUB	O
O	O	1350	1352	of	of	B-PP	IN	O	9	NMOD	O
O	O	1353	1360	ethanol	ethanol	B-NP	NN	O	10	PMOD	O
O	O	1361	1364	may	may	B-VP	MD	O	6	SBAR	O
O	O	1365	1371	affect	affect	I-VP	VB	O	12	VC	O
O	O	1372	1382	production	production	B-NP	NN	O	13	OBJ	O
O	O	1383	1385	of	of	B-PP	IN	O	14	NMOD	O
O	O	1386	1398	inflammatory	inflammatory	B-NP	JJ	B-protein	17	NMOD	B-protein
O	O	1399	1408	cytokines	cytokine	I-NP	NNS	I-protein	15	PMOD	I-protein
O	O	1408	1409	,	,	O	,	O	17	P	O
O	O	1410	1414	such	such	B-PP	JJ	O	20	PMOD	O
O	O	1415	1417	as	as	I-PP	IN	O	17	NMOD	O
T9	B-Protein	1418	1423	tumor	tumor	B-NP	NN	B-protein	23	NMOD	B-protein
T9	I-Protein	1424	1432	necrosis	necrosis	I-NP	NN	I-protein	23	NMOD	I-protein
T9	I-Protein	1433	1439	factor	factor	I-NP	NN	I-protein	25	NMOD	I-protein
T9	I-Protein	1439	1440	-	-	O	HYPH	O	25	P	O
T9	I-Protein	1440	1445	alpha	alpha	B-NP	SYM	O	30	NMOD	O
O	O	1445	1446	,	,	O	,	O	28	P	O
T10	B-Protein	1447	1458	interleukin	interleukin	B-NP	NN	B-protein	28	NMOD	B-protein
T10	I-Protein	1458	1459	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T10	I-Protein	1459	1460	1	1	I-NP	CD	I-protein	28	NMOD	I-protein
T10	I-Protein	1461	1465	beta	beta	B-NP	SYM	I-protein	34	NMOD	I-protein
O	O	1465	1466	,	,	O	,	O	34	P	O
O	O	1467	1470	and	and	O	CC	O	34	VMOD	O
T11	B-Protein	1471	1482	interleukin	interleukin	B-NP	NN	B-protein	34	NMOD	B-protein
T11	I-Protein	1482	1483	-	-	O	HYPH	I-protein	20	PMOD	I-protein
T11	I-Protein	1483	1484	6	6	B-NP	CD	I-protein	34	NMOD	I-protein
O	O	1485	1487	by	by	B-PP	IN	O	13	VMOD	O
O	O	1488	1498	disrupting	disrupt	B-VP	VBG	O	36	PMOD	O
T27	B-Entity	1499	1501	NF	NF	B-NP	NN	B-protein	42	NMOD	B-protein
T27	I-Entity	1501	1502	-	-	B-NP	HYPH	I-protein	42	NMOD	I-protein
T27	I-Entity	1502	1507	kappa	kappa	I-NP	NN	I-protein	42	NMOD	I-protein
T27	I-Entity	1508	1509	B	B	I-NP	NN	I-protein	42	NMOD	I-protein
O	O	1510	1519	signaling	signaling	I-NP	NN	O	37	OBJ	O
O	O	1520	1522	in	in	B-PP	IN	O	42	NMOD	O
O	O	1523	1532	monocytes	monocyte	B-NP	NNS	B-cell_type	43	PMOD	B-cell_type
O	O	1532	1533	.	.	O	.	O	5	P	O
